Armas MK, Santos HY, Olivera MOE, García RME, Armas PBA

Language: Spanish
References: 35
Page: 110-123
PDF size: 282.59 Kb.

ABSTRACT

Background: chylothorax is a serious disease, even more if it is bilateral and of a malignant cause; but it has treatment and the patient’s condition may be stable.
Objective: to present two patients of medical interest and prove that a good response from the treatment may be expected.
Clinical cases: two male patients with bilateral chylothorax and lymphoma were simultaneously attended at the hospital. Complementary diagnostic tests were made. The diagnosis of both patients turned out to be non-Hodgkin’s and Hodgkin’s lymphomas respectively. They were put on a diet in which fat was cut; the oncospecific treatment and repeated thoracocentesis were applied in both hemithoraxes. The first patient, after getting better from the bilateral effusion and initial symptoms, passed away 11 months later for not controlling the base disease. The second patient presented a stable condition of both complaints 18 months later. In both cases chylotorax was eased and it was not necessary to repeat the drainage. Analyses compared to other reports are made mainly when the lymphoma is the etiological cause; the adopted conduct coincides with other current studies.
Conclusions: the patients got better from bilateral chylothorax; one of them did not get a stable condition of his base disease and died and the second one is asymptomatic. A good therapeutic response may be obtained.

REFERENCES

1. Light RW. Trastornos mediastinicos y pleurales. En: Beer MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, editores. El Manual Merck de Diagnóstico y Tratamiento. 11 na ed. Madrid: Elsevier, 2007. p. 528-33.

2. Losso LC, Chefter MC. Penetrating thoracic trauma. En: Patterson GA, Cooper JD, Deslauriers J, Lerut A, Luketich JD, Rice TW, editors. Pearson´s Thoracic & Esophageal Surgery. 3 ra ed. London: Churchill Livingstone; 2008. p. 1777-86.

3. Piedra León I, Ruiz Martín J, Sevilla López S, Alkourdi Díaz A, Hernández Alarz F, Bayarri Lara CI, et al. Tratamiento quirúrgico del Quilotórax. Rev Esp Pat Quir 2010;22(1):90-6.

4. Light RW. Pleural Effusions. Med Clin N Am. 2011;95:1055-70.

5. Kirschner M. Tratado de técnica operatoria general y especial. T 4. 2da ed. Barcelona: Editorial Labor S.A.; 1944. p. 922-4.

6. Gutiérrez Macias A, Lizarralde Palacios E, Merino Múgica JM, Cabeza García S, Martínez Odríozola P, Miguel de la Villa F. Quilotórax bilateral en un caso de adenocarcinoma metastásico primario desconocido. Anales de Med Int. 2006;23(4):176-8.

7. Nair SK, Petko M, Hayward M. Aetiology and management of chylothorax in adults. Eur J Cardio-thoracic Sur. 2007;32:362-9.

8. Barili F, Polvani G, Topkara VK, Dainese L, Roberto M, Aljaber E, et al. Administration of octreotide for management of postoperative high-flow chylothorax. Ann Vasc Surg. 2007;21(1):9-2.

9. Machado Del Carvallo J, Suen Marquez V, Marchini Sergio J. Is oral nutrition therapy effective for the treatment of chylothorax? A case report. Nutrition. 2008;24:607-09.

10. Díaz Nueva G. Derrames pleurales quilosos (quilotórax y pseudoquilotórax). En: Pérez Rodríguez E, Villena Garrido MV, editores. Enfermedades de la pleura. Monografías NEUMOMADRID. 1ra ed. Madrid: Ergón; 2003. p.157-64.

11. Senosianin Lalastra C, Martínez González J, Mesomero Gismero F, Moreira Vicente V. Ascitis quilosa posquirúrgica en un adulto tratado con Octreótide. Gastroenterología y Hepatología. 2012;35(8):567-71.

12. Neveuc Rodrigo P, Fernández Reyes R, Buchcholtz Frías M, González Vigo M, Rodríguez Tavera J, Trujillo Rojo C, et al. Manejo conservador de la fístula quilosa postoperatoria con somatostatina. Rev Chil de Cir. 2006;58(3):219-23.

13. Gómez Caro A, Marrón Fernández C, Moradiellos Diez FJ, Díaz Hellin V, Pérez Antón JA, Martín de Nicolás JL. Tratamiento conservador con octreótido del quilotórax postquirúrgico. Arch Bronconeumol. 2004;40(10):473-5.

14. Cerdán Santa Cruz C, Idelfonso Martín JA, Santos Martín E, Méndez Montero JV, Torres García AJ. Embolización por vía percutánea de fístula del conducto torácico cervical. Cir Esp. 2011;89(5):325-7.

15. Sirvent Ochando M, López Villodre P, Martínez Segui MJ. Soporte nutricional y tratamiento con octreótido del quilotórax. Nutr Hosp.. 2010;25(1):113-9.

16. Mechán Méndez V, Morón Jorge J, Salas Mesa A, Cevallos Nieto P, Llanos Caldera F, Rojas Olmedo L, et al. Quilotórax bilateral asociado a linfoma no Hodgkin, folicular: génesis del quilotórax. Acta Méd Peruana. 2011;28(2):82-6

17. Cortés Téllez A, Sandoval R. Presentación no habitual del Linfoma Folicular. Arch Bronconeumol. 2011;47(1)56-7.

18. Skouras V, Kalomenidis I. Chylotorax. Diagnostic approach. Curr Opin Pulm Med. 2010;16:387-93.

19. Janjetovic S, Janning M, Daukeva L, Bokemeyer C, Fiedler W. Chylothorax in a patient with Hodgkin´s lymphoma: a case report and review of the literature. Tumori. 2013;99:e96-9.

20. Narita Y, Naoki K, Hida N, Okamoto H, Kunikane H, Omori T, et al. Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion. Nihon Kokyuki Gakkai Zasshi. 2008;46(2):120-5.

21. Prabhu V, Passant C. Left-sided neck dissection and chylothorax: a rare complication and its management. J Laryngol Otol. 2012;126(6):648-50.

22. Han C, Guo L, Wang KJ, Zhao JQ. Bilateral chylothorax following neck dissection for thyroid cancer. Int J Oral Maxillofac Surg. 2009;38(10):1119-22.

23. Bae JS, Song BJ, Kim MR, Park WC, Kim JS, Jung SS. Bilateral chylothoraces without chyle leakage after left-sided neck dissection for thyroid cancer: report of two cases. Surg Today. 2007;37(8):652-5.

24. Shah RD, Luketich JD, Schuchert MJ, Christie NA, Pennathur A, Landreneau RJ, et al. Quilotórax post esofagectomía. Ann Thorac Surg. 2012;93:897-904.

25. Cagol M, Ruol A, Castoro C, Alfieri R, Michieletto S, Ancona E. Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer. World J Surg. 2009;33:1684-6.

26. Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg. 2010;139:584-9.

27. Griffo S, De Luca G, Stassano R. Chylothorax after abdominal surgery. Gen Thorac Cardiovasc Surg. 2010;58(3):159-62.

28. Tsubokawa N, Hamai Y, Hihara J, Emi M, Miyata Y, Okada M. Laparoscopic thoracic duct clipping for persistent chylothorax after extrapleural pneumonectomy. Ann Thorac Surg. 2012;93(5):e131-2.

29. Tavera-DaSilva A, Hathaway O, Stylianou M, Moss J. Changes en lung function and chylou effusions in patients with lymphangioleiomyomatosis treated with sirolimus. J Ann Intern Med. 2011;154(12):797-805.

30. Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med. 2010;31(6):743-50.

31. Ananthan VS, Siva KK. A rare case of acid-fast bacilli in chylothorax. Lung India. 2012;29(2):166-8.

32. Honquero Martínez AF, Arnau Obrer A, Pérez Alfonso D, Estors Guerrero M, Cortés Alcaide CM, Cantó Armangod A. Bilateral chylotorax after delivery: an infrecuent case treated with videothoracoscopic talc pleurodesis. Cir Esp. 2006;80(6):400-2.

33. Milla Collado L, Jarabo Sarceda JR, Cal Vázquez I, Calatayud Gastardi J. Quilotórax. En: Guijarro Jorge R, González Aragoneses F, Sebastián Quetglás F, editores. Manual de urgencias en cirugía torácica. SECT. 1ra ed. Madrid: Adare Internacional; 2012. p. 133-35.

34. Ryu JH, Tomassetti S, Maldonado F. Undate on uncommon pleural effusions. Respirology. 2011;16(2):238-43.

35. Zárate Moreno FA, Oms Bernad LM, Mato Ruíz R, Balaguer del Ojo C, Sala Pedrós J, Campillo Alonso F. Eficacia del Octreótido en el tratamiento de la fístula quilosa asociada a enfermedades pancreáticas. Cir Esp. 2013;91(4):237-42.